For research use only. Not for therapeutic Use.
LPA5 Antagonist 1（Cat No.:I042822）is a selective inhibitor of the lysophosphatidic acid receptor 5 (LPA5), which is involved in various physiological processes such as cell migration, proliferation, and inflammatory responses. By blocking LPA5, this antagonist is used to study the role of LPA5 signaling in diseases like cancer, fibrosis, and neurological disorders. In preclinical research, LPA5 Antagonist 1 helps to explore the therapeutic potential of targeting LPA5 in conditions where its activity contributes to disease progression. This compound provides valuable insights for developing novel treatments aimed at modulating LPA5-related pathways.
| CAS Number | 2839471-45-1 |
| Synonyms | 4-(4-ethynylpiperidine-1-carbonyl)-6,7-dimethoxy-2-(3-methyl-1-benzothiophen-5-yl)isoquinolin-1-one |
| Molecular Formula | C28H26N2O4S |
| Purity | ≥95% |
| IUPAC Name | 4-(4-ethynylpiperidine-1-carbonyl)-6,7-dimethoxy-2-(3-methyl-1-benzothiophen-5-yl)isoquinolin-1-one |
| InChI | InChI=1S/C28H26N2O4S/c1-5-18-8-10-29(11-9-18)27(31)23-15-30(19-6-7-26-20(12-19)17(2)16-35-26)28(32)22-14-25(34-4)24(33-3)13-21(22)23/h1,6-7,12-16,18H,8-11H2,2-4H3 |
| InChIKey | KNTSYYKDKFNRKN-UHFFFAOYSA-N |
| SMILES | CC1=CSC2=C1C=C(C=C2)N3C=C(C4=CC(=C(C=C4C3=O)OC)OC)C(=O)N5CCC(CC5)C#C |
